How can we improve patient care with AI-imaging biomarkers?

During our 2025 Annual Member Meeting, Dr. George Harston, chief medical and innovation officer at Brainomix, spoke about how OSIC has catalyzed Brainomix’s work in ILD and pulmonary fibrosis – both in clinical care and clinical trials.